833 related articles for article (PubMed ID: 22398651)
1. Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP).
Mataseje LF; Bryce E; Roscoe D; Boyd DA; Embree J; Gravel D; Katz K; Kibsey P; Kuhn M; Mounchili A; Simor A; Taylor G; Thomas E; Turgeon N; Mulvey MR;
J Antimicrob Chemother; 2012 Jun; 67(6):1359-67. PubMed ID: 22398651
[TBL] [Abstract][Full Text] [Related]
2. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR
J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083
[TBL] [Abstract][Full Text] [Related]
3. Two distinct clones of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospitals.
Park YK; Choi JY; Jung SI; Park KH; Lee H; Jung DS; Heo ST; Kim SW; Chang HH; Cheong HS; Chung DR; Peck KR; Song JH; Ko KS
Diagn Microbiol Infect Dis; 2009 Aug; 64(4):389-95. PubMed ID: 19631092
[TBL] [Abstract][Full Text] [Related]
4. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
[TBL] [Abstract][Full Text] [Related]
5. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
Lee YT; Fung CP; Wang FD; Chen CP; Chen TL; Cho WL
J Microbiol Immunol Infect; 2012 Feb; 45(1):43-51. PubMed ID: 22169123
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
Park YK; Jung SI; Park KH; Kim SH; Ko KS
Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405
[TBL] [Abstract][Full Text] [Related]
7. A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumannii clinical isolates from Sweden belonging to different international clonal lineages.
Karah N; Giske CG; Sundsfjord A; Samuelsen Ø
Microb Drug Resist; 2011 Dec; 17(4):545-9. PubMed ID: 21830948
[TBL] [Abstract][Full Text] [Related]
8. Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit.
Tsakris A; Ikonomidis A; Poulou A; Spanakis N; Vrizas D; Diomidous M; Pournaras S; Markou F
Clin Microbiol Infect; 2008 Jun; 14(6):588-94. PubMed ID: 18397334
[TBL] [Abstract][Full Text] [Related]
9. Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil.
Schimith Bier KE; Luiz SO; Scheffer MC; Gales AC; Paganini MC; Nascimento AJ; Carignano E; Dalla Costa LM
Am J Infect Control; 2010 May; 38(4):308-14. PubMed ID: 20123152
[TBL] [Abstract][Full Text] [Related]
10. [Gram-negative bacteriae with resistance to carbapenems].
Nordmann P
Med Sci (Paris); 2010 Nov; 26(11):950-9. PubMed ID: 21106177
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of OXA-143 and alteration of outer membrane proteins in carbapenem-resistant Acinetobacter spp. isolates in Brazil.
Mostachio AK; Levin AS; Rizek C; Rossi F; Zerbini J; Costa SF
Int J Antimicrob Agents; 2012 May; 39(5):396-401. PubMed ID: 22455794
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.
Davies TA; Marie Queenan A; Morrow BJ; Shang W; Amsler K; He W; Lynch AS; Pillar C; Flamm RK
J Antimicrob Chemother; 2011 Oct; 66(10):2298-307. PubMed ID: 21775338
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study.
Kiratisin P; Chongthaleong A; Tan TY; Lagamayo E; Roberts S; Garcia J; Davies T
Int J Antimicrob Agents; 2012 Apr; 39(4):311-6. PubMed ID: 22386743
[TBL] [Abstract][Full Text] [Related]
14. Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration.
Landman D; Babu E; Shah N; Kelly P; Olawole O; Bäcker M; Bratu S; Quale J
J Antimicrob Chemother; 2012 Jun; 67(6):1427-31. PubMed ID: 22378678
[TBL] [Abstract][Full Text] [Related]
15. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden.
Samuelsen Ø; Naseer U; Tofteland S; Skutlaberg DH; Onken A; Hjetland R; Sundsfjord A; Giske CG
J Antimicrob Chemother; 2009 Apr; 63(4):654-8. PubMed ID: 19218573
[TBL] [Abstract][Full Text] [Related]
16. Detection of OXA-type carbapenemases and integrons among carbapenem-resistant Acinetobactor baumannii in a teaching hospital in China.
Hu Q; Hu Z; Li J; Tian B; Xu H; Li J
J Basic Microbiol; 2011 Oct; 51(5):467-72. PubMed ID: 21656808
[TBL] [Abstract][Full Text] [Related]
17. Comparison of in-house and commercial real time-PCR based carbapenemase gene detection methods in Enterobacteriaceae and non-fermenting gram-negative bacterial isolates.
Smiljanic M; Kaase M; Ahmad-Nejad P; Ghebremedhin B
Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):48. PubMed ID: 28693493
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy.
Mezzatesta ML; D'Andrea MM; Migliavacca R; Giani T; Gona F; Nucleo E; Fugazza G; Pagani L; Rossolini GM; Stefani S
Clin Microbiol Infect; 2012 Feb; 18(2):160-6. PubMed ID: 21722261
[TBL] [Abstract][Full Text] [Related]
19. Detection and spread of carbapenem-resistant Citrobacter freundii in a teaching hospital in China.
Chen S; Hu F; Liu Y; Zhu D; Wang H; Zhang Y
Am J Infect Control; 2011 Nov; 39(9):e55-60. PubMed ID: 21705111
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of OXA-51-type class D beta-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centres.
Vahaboglu H; Budak F; Kasap M; Gacar G; Torol S; Karadenizli A; Kolayli F; Eroglu C
J Antimicrob Chemother; 2006 Sep; 58(3):537-42. PubMed ID: 16816400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
